ABOUT IPS

IPS-Integrated Project Services is a global provider of technical consulting, architecture, engineering, project controls, construction management, and CGMP compliance services for technically complex pharmaceutical development and manufacturing facilities worldwide.

FEATURED SERVICES

Our internationally recognized team of experts bring to clients an unmatched level of skills, knowledge and business acumen gained from years of industry experience, including at pharmaceutical companies and equipment suppliers. They have completed over $3 billion in aseptic capital projects and have over 300 years of combined aseptic processing experience.

Our team of design experts collaborate with our clients to envision a facility's strategic future - evaluating its current capacity versus the long-term needs. We interview stakeholders and users, collect, document, and analyze resourcing, building, and process data to build a road map to guide decision making.

Our highly specialized team of process architects - one of the deepest and strongest in the world - work with our clients to design facilities and processes that manufacture the most technically advanced, scientific products in the pharmaceutical and life sciences industries.

IPS is the recognized leader in the design of technically complex product development and manufacturing facilities around the world. Our cross-functional approach to design delivers value throughout the entire design process; from feasibility studies through detailed design and construction assistance.

Our cross functional teams of technical and subject matter experts, many of whom come from industry, have successfully collaborated with clients around the world to produce facility and site master plans identify the gaps between business needs and facility and site assets. Our proven five-step process of: aligning, collecting, analyzing, developing, and recommending achieves an outcome focused on the goals and objectives.

The construction management team delivers comprehensive turnkey construction management services spanning the entire execution process - from pre-design consulting, constructability analysis, through occupancy - across geographic regions, industry sectors, and facility types. We utilize lean construction and project delivery tools and techniques including offsite and modular construction to reduce waste and build value throughout each phase of project delivery, without compromising safety.

Our technical automation and instrumentation experts continuously evaluate and implement automation technologies and systems that move us toward Industry 4.0. Our experts deliver solutions in automation strategies and evaluation, SCADA and control system upgrades, building automation, and technology obsolescence management plans.

Our industry-leading compliance subject matter experts combine their technical and operational expertise in the areas of design, construction, commissioning, qualification, and validation to produce fully operational and compliant commercial operations.

Using our integrated EPCMV process allows us to deliver exceptional manufacturing facilities to the clients we serve. We understand the complex nature of the systems and structures in the facilities we produce. From bioreactors to powder transfer systems, cosmetics to medical devices, we are at the forefront of the latest advances in the industry. Our approach takes a holistic view of each project. We provide the latest, proven concepts to deliver exceptional results for the clients we serve.

Our team has the experience and technical knowledge to execute the most complex, demanding laboratory projects. Our unique approach combines the design elements with operational excellence, energy efficiency and risk and safety assessment as required to meet your specialty lab needs. 

At the forefront of the industry, our experts continuously acquire knowledge on the latest technologies, equipment, and methodologies to prepare goods for distribution. The IPS packaging teams tailor solutions to the unique challenges and desires of our clients. Partnerships with our clients are key to a successful project that produces a result specific to the project goals and objectives. Working together, we define a balance between efficiency, flexibility, quality, and cost that is unique to each facility and installation all the while maintaining focus on regulatory requirements.

IPS and GCON have partnered to create iCON, a turnkey modular facility platform solution for the biomanufacturing industry. The collaboration provides the most flexible and rapidly deployable facility platform, meeting the modular and mobile demands of the industry. The iCONteam's broad range of technical capabilities and services along with prefabricated cleanroom PODs provides a true turnkey solution to biopharmaceutical manufacturers and CMOs with needs for production agility and capacity flexing.

We are internationally recognized as experts in advanced aseptic processing and risk-based isolation and barrier technologies. Our experience, awareness and understanding of industry trends places importance on time-to-market, plant flexibility and cost control to avoid costly project delays and minimize risk.

Whether the products are new or existing, our Drug Development and Technology Transfer services offer solutions that consistently maintain quality and compliance to effectively accelerate scale-up through market launch. Our experts provide ideas that speed pharmaceutical and biotech products to market.

Our team has the experience and technical knowledge to execute the most complex, demanding laboratory projects. Our unique approach combines the design elements with operational excellence, energy efficiency and risk and safety assessment as required to meet your laboratory needs.

Knowing the technology, industry trends, regulatory environment and manufacturing processes enables our process/bioprocess engineers to identify opportunities to streamline production and maximize efficiency.

With technical expertise spanning R&D to pilot-scale and large-scale production, our team knows the technology, trends and regulatory environment to successfully deliver any sized project. Our unique approach and technical expertise enables us to significantly improve operational capabilities, throughput and process control, optimize cost and minimize risk.

With biomanufacturing technical expertise spanning R&D to pilot-scale and large-scale production, our team knows the technology, trends and regulatory environment to successfully deliver any sized project. Our unique approach and technical expertise enables us to significantly improve operational capabilities, throughput and process control, optimize cost and minimize risk.

We provide the knowledge, flexibility and technical expertise through our risk-based approach designed to reduce risk, lower costs, improve efficiency and productivity and comply with mandates and requirements. We minimize the impact of operations through energy management programs and our unique solutions to modernize facilities and reduce the environmental footprint.

For over twenty-five years, IPS has delivered fully integrated Engineering, Construction, Project Controls, Commissioning and Qualification services to the pharmaceutical industry. Our team imparts Knowledge, Skill and Passion to develop solutions that improve efficiency, productivity, financial performance and minimize overall cost and risk.

CONTACT INFORMATION

IPS-Integrated Project Services

721 Arbor Way, Suite 100

Blue Bell, PA 19422

UNITED STATES

Phone: 610.828.4090

Contact: Sales

FEATURED ARTICLES

  • The Cardinal Group was awarded the project based on an integrated delivery approach, with IPS as the Engineer of Record. Their combined technical expertise and experience is critical to the success of this aggressive schedule-driven project.

  • IPS designed a new 4x2000L (maximum production scale) multi-product, multi-phase monoclonal antibody and vaccine production facility. The greenfield site was designed to seed, scale up, harvest, and purify cell culture and vaccine products utilizing up to 100% single-use systems. The concept included six manufacturing modules of which four were identical to allow for process flexibility of different unit operations, scales, and phases of material. The other two were designed to accommodate formulation of buffer and/or media as well as other additives.

  • Our client’s objective for the flex fill project was to install a new, independent filling suite for manufacturing specialized sterile injectable products. The new line would increase capacity with a state-of-the-art flexible filling line and associated ancillary support functions. This new capability was important as a CMO. Manufacturing continued throughout the duration of the project.

  • Read how the sources of inefficiency are reduced and so are the hazards when construction components are manufactured off-site and delivered on-time.

  • Biomanufacturers seeking the best approach to rapid implementation of flexible manufacturing capacity take into account the benefits presented by different modular construction options. Here we analyze different approaches to building manufacturing capacity and assess the economic benefits of each approach.

  • Utilizing a wide range of expertise, IPS team members interfaced with MilliporeSigma’s operational group to design new layouts and processes that would optimize the facility’s flow and throughput.

  • Disagreements about design elements, execution, risk-management solutions, and safety standards are inevitable when multiple teams are working together on a project, and this can be amplified when working with teams in countries with different cultures. There are certain principles that need to be nurtured in successful project executions. To demonstrate how to effectively overcome execution challenges in a real-world project scenario, here are ten examples from our recently completed Bavarian Nordic Fill and Finish Facility for Live Viral Vaccines.

  • There are many factors in the site selection and facility design of cell therapy facilities. We summarize our experience and findings over the last five years of consideration factors behind the vertical vs. horizontal decision.

  • While companies are racing to find a vaccine and therapies to help patients, the last thing they need is for traditional construction delivery methods to challenge or even sabotage their production goals. Following are 12 strategies and solutions for accelerating the design and construction process that can yield record breaking delivery times.

  • Laboratories are an integral part of the pharmaceutical industry. They are used at each stage of the product development. See how this solution allows you to plan projects without having to build new labs and gain the ability to plan projects better, inventory management, being nimble in responding to demand fluctuations, avoidance of under and/or over utilization of talent and reliable capital project planning that is based on actual utilization tracking.

  • IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation (EPCMV) services, announces the opening of their newest office in the San Francisco Bay Area.

  • Effective vaccine production facility planning combines technological innovation, streamlined workflows, and savvy budget management to ensure project speedbumps don’t become roadblocks.

  • Both newly designed and retrofitted HVAC systems can be effective in mitigating the airborne transmission of COVID-19 and other pathogens. 

  • Learn about United Therapeutics winning the Social Impact category for the 2020 ISPE Facility of the Year Award:

  • IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation (EPCMV) services, announces an employee retention plan that secures jobs for their entire global staff, nearly 1,400 employees.

  • One of the most significant moves for a growing biotech or pharmaceutical company — sometimes considered as a graduation step — is the acquisition of property to conduct clinical trials and manufacture commercial products. In the first installment of this two-part series, we will explore what considerations companies need to make before they decide what type of property to pursue.

  • Autologous (patient-derived) therapies represent unique challenges to processing. One-patient, single-batch is a radical change from the scale our industry is accustomed to. At this level the filling is more analogous to limited Phase 1 clinical trial materials or even preclinical applications. The logistics and required compliance of manufacturing these personalized therapies is drastically different and presents a combinatorial explosive problem. One aspect of this process where traditional methods fall apart is filling of these therapies.

  • Expansions and renovations to existing biological facilities, and construction of new facilities, provide a unique opportunity to rethink basic design strategies and use new technologies to build a better facility that will improve compliance. This article is the sixth in a six-part series on how single-use systems (SUS) are changing the modern biotechnology facility design and construction paradigm.

  • Cell therapies have the potential to revolutionize the biopharmaceutical world, but today’s processes, logistics, and delivery make for a challenging entry into the sector’s growth curve. As the industry evolves, we have to answer (at least) three important questions when bringing these exciting new therapies to market.

  • In 1931, Swiss doctor Paul Niehans injected a preparation of live cells from a parathyroid gland into a dying patient. The patient subsequently recovered, and Dr. Niehans had a eureka moment — that injections of living cells can have tremendous therapeutic value.